Behind The Labs - Episode 56 - Preventing and Reversing Neurodegenerative Diseases and the Physiological-Psychological Connection that Can Help Identify Personalized Medicine and Medication!
About this episode
This episode discusses groundbreaking research in neuroscience and medicine aimed at preventing and reversing neurodegenerative diseases.
In this episode of Behind The Labs , we broke down five major research studies pushing the boundaries of neuroscience and medicine. We covered Northwestern's experimental drug NU-9, which may prevent Alzheimer's before symptoms ever appear by targeting a newly identified toxic amyloid subtype. We then talked about Japanese researchers engineering a supercharged vitamin K compound that can actually regenerate lost neurons — a first for the field. Johns Hopkins blew our minds with pea-sized lab-grown brains that can distinguish schizophrenia from bipolar disorder with 92% accuracy, opening the door to personalized psychiatric treatment. On the prevention side, a massive meta-analysis confirmed that eating legumes and soy foods daily can cut hypertension risk by nearly 30%, and NYU researchers found a simple blood test that detects depression through accelerated immune cell aging — before you even feel it. The big theme across all of it: medicine is shifting from treating disease after the damage is done to catching and stopping it years earlier.
Topics covered
- neurodegenerative diseases
- personalized medicine
- neuroscience research
- mental health
- preventive medicine
- diet and health
Mentioned in this episode
Organizations: Northwestern, Johns Hopkins, NYU
Products: NU-9
More episodes of Behind The Labs
Explore listener stats, chart rankings, contacts and more on the Behind The Labs podcast page.